Xiaomin Hu

Xiaomin Hu

Auto-generated profile, based on publicly available information

Xiaomin Hu

College of Chemistry and Chemical Engineering, Key Laboratory for Chemical Biology of Fujian Province, High-field NMR Center, Xiamen University, Xiamen, 361005, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
JGJinping Gu
Jinping Gu
XHXiaomin Hu
Xiaomin Hu
WSWei Shao
Wei Shao
TJTianhai Ji
Tianhai Ji
WYWensheng Yang
Wensheng Yang
Dong-Hai LinDong-Hai Lin
Dong-Hai Lin
Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis

5 May 2020 in Cancer Science
Verified
Journal Article
Open access
PDF file
JGJinping Gu
Jinping Gu
CHCaihua Huang
Caihua Huang
XHXiaomin Hu
Xiaomin Hu
Jinmei XiaJinmei Xia
Jinmei Xia
WSWei Shao
Wei Shao
Dong-Hai LinDong-Hai Lin
Dong-Hai Lin
Gastric cancer (GC) is one of the deadliest cancers worldwide, and the progression of gastric carcinogenesis (GCG) covers multiple complicated pathological stages. Molecular mechanisms of GCG are still unclear. Here, we undertook NMR‐based metabolomic analysis of aqueous metabolites extracted from gastric tissues in an established rat model of GCG. We showed that the metabolic profiles were clearly distinguished among 5 histologically classified groups: control, gastritis, low‐grade gastric dysplasia, high‐grade gastric dysplasia (HGD), and GC. Furthermore, we carried out metabolic pathway analysis based on identified significant metabolites and revealed significantly disturbed metabolic pathways closely associated with the 4 pathological stages, including oxidation stress, choline phosphorylation, amino acid metabolism, Krebs cycle, and glycolysis. Three metabolic pathways were continually disturbed during the progression of GCG, including taurine and hypotaurine metabolism, glutamine and glutamate metabolism, alanine, aspartate, and glutamate metabolism. Both the Krebs cycle and glycine, serine, and threonine metabolism were profoundly impaired in both the HGD and GC stages, potentially due to abnormal energy supply for tumor cell proliferation and growth. Furthermore, valine, leucine, and isoleucine biosynthesis and glycolysis were significantly disturbed in the GC stage for higher energy requirement of the rapid growth of tumor cells. Additionally, we identified potential gastric tissue biomarkers for metabolically discriminating the 4 pathological stages, which also showed good discriminant capabilities for their serum counterparts. This work sheds light on the molecular mechanisms of GCG and is of benefit to the exploration of potential biomarkers for clinically diagnosing and monitoring the progression of GCG.